Aerovate Therapeutics, Inc.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: US0080641071

USD

12.40

0.78 (6.71%)

Dec 04

NAS

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

AnaptysBio, Inc.

Caribou Biosciences, Inc.

Janux Therapeutics, Inc.

Avidity Biosciences, Inc.

Agenus, Inc.

UroGen Pharma Ltd.

Mineralys Therapeutics, Inc.

iTeos Therapeutics, Inc.

Aerovate Therapeutics, Inc.

Nautilus Biotechnology, Inc.

AN2 Therapeutics, Inc.

Why is Aerovate Therapeutics, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Aerovate Therapeutics, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Aerovate Therapeutics, Inc.

-86.48%

-0.15

288.81%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-18.48%

EBIT to Interest (avg)

-67.20

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.01

Sales to Capital Employed (avg)

Tax Ratio

0.11%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.09

EV to EBIT

1.30

EV to EBITDA

1.30

EV to Capital Employed

69.28

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

5336.50%

ROE (Latest)

-65.24%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bearish

Bullish

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

NET PROFIT(HY)

Higher at USD -28.47 MM

ROCE(HY)

Highest at -38.06%

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

EPS(Q)

Highest at USD -1.13

-3What is not working for the Company

OPERATING PROFIT(Q)

Lowest at USD -27.78 MM

PRE-TAX PROFIT(Q)

Lowest at USD -25.95 MM

NET PROFIT(Q)

Lowest at USD -25.95 MM

Here's what is working for Aerovate Therapeutics, Inc.

EPS

Highest at USD -1.13

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Aerovate Therapeutics, Inc.

Operating Profit

Lowest at USD -27.78 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit

Lowest at USD -25.95 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit

Lowest at USD -25.95 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)